Bosnalijek Competitors and Similar CompaniesClear all

Bosnalijek's competitors and similar companies include Soiken Holdings, Biogenesis, Lavipharm and Inpharma.

	Bosnalijek Bosnalijek is a manufacturer of medicines.	Soiken Holdings Soiken Holdings (総医研ホールディングスにつ) is a company that researches and develops biomarkers.	Biogenesis Biogenesis is a contract manufacturing company.	Lavipharm Lavipharm develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products.	Inpharma Inpharma is a company engaged in the production, commercialization and export of medicines.
Founding Date	Founding Date 1951	Founding Date 1994	Founding Date 1997	Founding Date 1911	Founding Date 1991
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare consumer goods cosmetics drug development pharma	Tags Healthcare cosmetics drug development pharma	Tags Healthcare cosmetics drug development	Tags Healthcare Retail consumer goods cosmetics distribution drug development pharma	Tags Healthcare cosmetics drug development
Locations	Locations Sarajevo, BA HQ Tirana, AL Zagreb, HR Podgorica, ME Moskva, RU Beograd, RS Kyiv, UA	Locations Toyonaka, JP HQ	Locations Paterson, US HQ	Locations Attica, GR HQ	Locations Praia, CV HQ
Employees	Employees 154	Employees 90	Employees 1571% increase	Employees 299	Employees N/A
Valuation ($)	Valuation ($) N/A	Valuation ($) 23.3 m	Valuation ($) N/A	Valuation ($) 140.1 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥4.8b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €56.4m (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ¥2.4b (FY, 2025)	Cost of goods N/A	Cost of goods €26.7m (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥2.4b (FY, 2025)	Gross profit N/A	Gross profit €32.3m (FY, 2024)	Gross profit N/A
Net income	Net income N/A	Net income (¥211.4m) (FY, 2025)	Net income N/A	Net income €9m (FY, 2024)	Net income N/A